Motus GI Holdings – Consensus Indicates Potential 157.7% Upside

Broker Ratings

Motus GI Holdings with ticker code (MOTS) have now 6 analysts covering the stock. The analyst consensus points to a rating of ‘Strong_Buy’. The target price ranges between 3 and 2 with the average target price sitting at 2.5. Given that the stocks previous close was at 0.97 this is indicating there is a potential upside of 157.7%. There is a 50 day moving average of 0.9 and the 200 day moving average is 1.05. The company has a market capitalisation of $32m. Visit the company website at: http://www.motusgi.com

Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index